Blood advances · 2026 Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B-cell lymphoma. Yoon SE, Kang W, Cho J, et al. Bacteroides fragilisFaecalibacterium prausnitzii PubMed ↗
Frontiers in immunology · 2023 Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma. Zhang Y, Han S, Xiao X, et al. Streptococcus parasanguinisStreptococcus salivarius PubMed ↗